EA201200196A1 - Составы для ухода за полостью рта, содержащие человеческий рекомбинантный интерлейкин-1 - Google Patents
Составы для ухода за полостью рта, содержащие человеческий рекомбинантный интерлейкин-1Info
- Publication number
- EA201200196A1 EA201200196A1 EA201200196A EA201200196A EA201200196A1 EA 201200196 A1 EA201200196 A1 EA 201200196A1 EA 201200196 A EA201200196 A EA 201200196A EA 201200196 A EA201200196 A EA 201200196A EA 201200196 A1 EA201200196 A1 EA 201200196A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- human recombinant
- recombinant interleukin
- oral cavity
- compositions
- care
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
Данное изобретение относится к составам по уходу за полостью рта, в состав которых входит человеческий рекомбинантный интерлейкин-1 и его методы применения для поддержания полости рта в хорошем состоянии, уменьшения неприятного запаха из полости рта и/или профилактики или лечения заболеваний пародонта. Предпочтительно, чтобы человеческим рекомбинантным интерлейкином-1 являлся человеческий рекомбинантный интерлейкин-1 альфа или бета.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2009/062639 WO2011038754A1 (en) | 2009-09-29 | 2009-09-29 | Oral care compositions containing human recombinant interleukin-1 |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201200196A1 true EA201200196A1 (ru) | 2012-07-30 |
EA019332B1 EA019332B1 (ru) | 2014-02-28 |
Family
ID=42715271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201200196A EA019332B1 (ru) | 2009-09-29 | 2009-09-29 | Состав для ухода за полостью рта, содержащий человеческий рекомбинантный интерлейкин-1 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20120219511A1 (ru) |
EP (1) | EP2464330B1 (ru) |
JP (1) | JP5661777B2 (ru) |
KR (1) | KR101533316B1 (ru) |
CN (1) | CN102573788B (ru) |
BR (1) | BR112012007399A2 (ru) |
EA (1) | EA019332B1 (ru) |
TW (1) | TWI478722B (ru) |
UA (1) | UA101459C2 (ru) |
WO (1) | WO2011038754A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9917885B2 (en) | 2013-07-30 | 2018-03-13 | International Business Machines Corporation | Managing transactional data for high use databases |
KR101610861B1 (ko) | 2014-07-28 | 2016-04-11 | (주)케어젠 | 골분화 촉진능 및 치주인대섬유모세포 활성 촉진능을 갖는 펩타이드 및 이의 용도 |
KR20180124132A (ko) * | 2016-03-29 | 2018-11-20 | 세이프화이트 인코포레이티드 | 치아 및 치아 구성요소의 미백을 위한 고분자 전해질 치과용 접착제 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0200986B2 (en) * | 1985-04-25 | 1998-03-11 | F. Hoffmann-La Roche Ag | Recombinant human interleukin-1 |
US4801686A (en) * | 1986-09-04 | 1989-01-31 | Immunex Corporation | Purification of recombinant interleukin-1 |
ATE92766T1 (de) * | 1987-12-18 | 1993-08-15 | Immunex Corp | Oertliche wundheilmittel, die interleukin-1proteine enthalten. |
US5202118A (en) * | 1987-12-18 | 1993-04-13 | Immunex Corporation | Method for promoting wound healing using IL-1 |
ZA89202B (en) * | 1988-01-15 | 1989-09-27 | Hoffmann La Roche | Recombinant human interleukin-1 alpha polypeptides |
US5120534A (en) * | 1988-07-29 | 1992-06-09 | Otsuka Pharmaceutical Co., Ltd. | IL-1α derivatives and medicament for treating thrombocytopenia |
US5827534A (en) * | 1995-05-24 | 1998-10-27 | University Of Maryland At Baltimore | Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery |
US6413760B1 (en) * | 1997-04-15 | 2002-07-02 | Genetics Institute, Inc. | Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof |
ID20480A (id) * | 1997-10-02 | 1998-12-24 | Lg Chemical Ltd | Komposisi untuk mencegah atau mengobati penyakit periodontal yang terdiri dari ekstrak dari achyranthis radix atau ulmus cortex |
US8283135B2 (en) * | 2000-06-30 | 2012-10-09 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
JP2002200161A (ja) * | 2000-10-24 | 2002-07-16 | Menicon Co Ltd | 培養皮膚代替物の製造方法およびそれにより得られる培養皮膚代替物 |
US20030105027A1 (en) * | 2001-11-06 | 2003-06-05 | Rosenbloom Richard A. | Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
US20080230298A1 (en) * | 2003-09-18 | 2008-09-25 | Robert Michael Buch | Method of Applying Oral Compositions |
PL2319500T3 (pl) * | 2004-03-12 | 2013-05-31 | Biodel Inc | Szybko działające kompozycje do dostarczania leku |
DE602005025111D1 (de) * | 2004-05-03 | 2011-01-13 | Interleukin Genetics Inc | Diagnostika und therapeutika für mit einem entzündlichen il-1-haplotyp assoziierte krankheiten |
WO2006026604A2 (en) * | 2004-08-27 | 2006-03-09 | Advanced Viral Research Corp. | Methods for promoting wound healing |
US20080008663A1 (en) * | 2006-07-10 | 2008-01-10 | Wm. Wrigley Jr. Company | Method of reducing inflammation |
GB0619786D0 (en) * | 2006-10-06 | 2006-11-15 | Inst Of Technology Sligo | An antimicrobial and immunostimulatory system |
-
2009
- 2009-09-29 BR BR112012007399A patent/BR112012007399A2/pt not_active IP Right Cessation
- 2009-09-29 JP JP2012531243A patent/JP5661777B2/ja not_active Expired - Fee Related
- 2009-09-29 US US13/395,688 patent/US20120219511A1/en not_active Abandoned
- 2009-09-29 EA EA201200196A patent/EA019332B1/ru not_active IP Right Cessation
- 2009-09-29 KR KR1020127008138A patent/KR101533316B1/ko active IP Right Grant
- 2009-09-29 CN CN200980161579.7A patent/CN102573788B/zh active Active
- 2009-09-29 UA UAA201205107A patent/UA101459C2/ru unknown
- 2009-09-29 EP EP09736580.3A patent/EP2464330B1/en active Active
- 2009-09-29 WO PCT/EP2009/062639 patent/WO2011038754A1/en active Application Filing
-
2010
- 2010-09-28 TW TW099132770A patent/TWI478722B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW201117823A (en) | 2011-06-01 |
UA101459C2 (ru) | 2013-03-25 |
CN102573788B (zh) | 2014-05-21 |
US20120219511A1 (en) | 2012-08-30 |
EA019332B1 (ru) | 2014-02-28 |
EP2464330A1 (en) | 2012-06-20 |
JP5661777B2 (ja) | 2015-01-28 |
TWI478722B (zh) | 2015-04-01 |
KR101533316B1 (ko) | 2015-07-03 |
EP2464330B1 (en) | 2016-03-23 |
WO2011038754A1 (en) | 2011-04-07 |
JP2013505972A (ja) | 2013-02-21 |
KR20120081593A (ko) | 2012-07-19 |
CN102573788A (zh) | 2012-07-11 |
BR112012007399A2 (pt) | 2016-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119596T1 (el) | Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης | |
ATE551063T1 (de) | Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen | |
MY152710A (en) | Oral compositions containing extracts of garcinia mangostana l. and related methods | |
MX2011003473A (es) | Composiciones para el cuidado bucal. | |
MX2018009945A (es) | Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad. | |
MY150855A (en) | Oral compositions containing extracts of zizyphus joazeiro and related methods | |
DOP2012000246A (es) | Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf) | |
NO20092637L (no) | Fremgangsmater for behandling | |
EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
EA200971053A1 (ru) | Способы лечения кожных язв | |
MY160412A (en) | Oral compositions containing extracts of zingiber officinale and related methods | |
EA201291336A1 (ru) | Замещенные 5-фтор-1н-пиразолопиридины и их применение | |
BRPI0921002A8 (pt) | Composições para tratamento bucal compreendendo sílica fundida e seu uso | |
EA201270575A1 (ru) | Соединения | |
BR112012015750A2 (pt) | composição para higiene oral, método para melhorar o cumprimento de um plano de tratamento pelo paciente com uma composição para higiene oral, e, método para branqueamento de uma superfície dental | |
EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
EA201391119A1 (ru) | Системы доставки наночастиц, их получение и применение | |
MY150829A (en) | Oral compositions containing extracts of myristica fragrans and related methods | |
WO2014141210A3 (en) | Multifunctional immature dental pulp stem cells and therapeutic applications | |
EA201171215A1 (ru) | Стоматологическое анестезирующее средство для интраназального введения, содержащее тетракаин и вазоконстриктор | |
CY1116234T1 (el) | Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
EA201690612A1 (ru) | Составы зубной пасты для доставки аллергенов в слизистую оболочку полости рта | |
BRPI0907220A2 (pt) | métodos de tratar distúrbios de perda óssea usando um antagonista de gm-csf | |
CY1116158T1 (el) | Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
EA201200196A1 (ru) | Составы для ухода за полостью рта, содержащие человеческий рекомбинантный интерлейкин-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |